Lisa Radcliffe’s son, George, was diagnosed with rhabdomyosarcoma when he was three years old and sadly died when he was four. Here, she explains how she and her husband, David, quickly found their own approach to communicating with George during his treatment, and how this helped them.
Ellie Philpotts was diagnosed with Hodgkin lymphoma in 2011 aged 15. She explains how she found support from other young people with cancer and how, through awareness raising, writing and advocacy work, she’s hoping to help those who are newly diagnosed.
Defining the molecular landscape of paediatric and adolescent acute leukaemia in Tanzania
This year, for Childhood Cancer Awareness Month (CCAM), CCLG has been working hard to raise awareness of the long-term impact of childhood cancer and its treatments.
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
First formed to establish clinical trials in childhood cancer, research has always been an integral part of CCLG’s work. Ellie Ellicott, CCLG Research Communications Executive, tells us more about its research journey and how the experiences of those that matter the most are helping shape future directions.
Supportive care is an area of children’s cancer care that has progressed significantly in recent decades. Dr Bob Phillips and Dr Jess Morgan, members of CCLG’s Supportive Care working group, explain just some of the ways it has improved to help patients and their families cope with their disease and the treatment of it.
Jake Andrade was first diagnosed with leukaemia as a 13-year-old, before relapsing aged 19. Now 21, he tells us about the goals he set to help him through his second treatment and recovery, and how he has published a book to help other young people with cancer
It’s not just the type of treatments that doctors look to improve, but the way they can be delivered so they are safer and more effective, too. We hear from two leading experts on already established advancements in eye cancer treatment, and a developing example of progress in brain tumour therapy.
